79 related articles for article (PubMed ID: 9545794)
1. [Current principles of diagnosis and treatment of chronic lymphocytic B-cell leukemia].
Losonczy H
Orv Hetil; 1998 Mar; 139(11):611-9. PubMed ID: 9545794
[TBL] [Abstract][Full Text] [Related]
2. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
3. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Robak T; Kasznicki M
Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
[TBL] [Abstract][Full Text] [Related]
5. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukaemia: only treat when symptomatic.
Prescrire Int; 2002 Oct; 11(61):156-7. PubMed ID: 12378749
[TBL] [Abstract][Full Text] [Related]
8. [Advances in the treatment of chronic lymphocytic leukemia (CLL)].
Lechner K; Jäger U; Geissler K; Greinix H; Kalhs P
Wien Klin Wochenschr; 1998 Oct; 110(20):701-8. PubMed ID: 9857427
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukaemia: current first-line therapy.
Carney DA; Mulligan SP
Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. [Chronic lymphocytic leukemia. 2. Therapy].
Hallek M; Schmitt B; Emmerich B; Stein H
Dtsch Med Wochenschr; 2001 Jun; 126(23):690-5. PubMed ID: 11441667
[No Abstract] [Full Text] [Related]
12. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Molica S; Vacca A; Tucc L; Ribatti D
Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392
[TBL] [Abstract][Full Text] [Related]
13. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Kay NE
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
[TBL] [Abstract][Full Text] [Related]
15. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M
Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494
[TBL] [Abstract][Full Text] [Related]
16. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
[TBL] [Abstract][Full Text] [Related]
17. [Chronic lymphatic leukemia. A population-based study of symptoms, findings, complications and choice of treatment].
Ly B; Hammerstrøm J; Bergheim J; Dahl IM; Grøttum KA; Lødemel B
Tidsskr Nor Laegeforen; 1998 Jan; 118(2):228-32. PubMed ID: 9485617
[TBL] [Abstract][Full Text] [Related]
18. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
19. Management of symptomatic, untreated chronic lymphocytic leukemia.
Kasamon YL; Flinn IW
Blood Rev; 2007 May; 21(3):143-56. PubMed ID: 17097783
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Richards S
Cancer Treat Rev; 2005 Jun; 31(4):332-5. PubMed ID: 15894429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
